|
(Health-NewsWire.Net, September 29, 2021 ) According to the new market research report “European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) – Forecast”, published by MarketsandMarkets™, the Mammography Workstations Market is projected to reach USD 14 million by 2024 from USD 10 million in 2018, at a CAGR of 5.5% during the forecast period.
Recent Development in Mammography Workstations Market;
- In February 2019, Fujifilm (Japan) launched ASPIRE Bellus II.
- In January 2018, Agfa-Gevaert NV (Belgium) signed a contract with the West Suffolk NHS Foundation Trust (UK) in order to implement enterprise imaging for radiology platform.
- In May 2017, Siemens AG (Germany) and Fraunhofer MEVIS (Germany) entered into a partnership for developing artificial intelligence software systems to facilitate diagnosis and therapy decisions in order to support physicians to define the best possible treatment approach.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101392240
Geographically; Germany accounted for the largest share of the mammography workstations market in 2018. The large share of Germany is primarily attributed to the better reimbursement scenario in the country as compared to other European countries, wider acceptance of multimodality mammography workstations among major end users (such as hospitals, surgical clinics, and breast care centers), and the rising patient demand for improved cancer screening.
General Electric (US), Siemens (Germany), FUJIFILM Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy) are the major players in the mammography workstations market.
GE Healthcare (US) (a key business division of General Electric Company) is among the top players involved in the development of multimodality mammography workstations. The company focuses on maintaining its leading position in the European mammography workstations market through organic growth strategies such as product launches. Over the years, GE Healthcare has strengthened its customer base and increased its market penetration in the UK, Germany, France, Italy, Spain, Sweden, and Spain. Due to its strong brand image and excellent geographic reach, the company is likely to hold the top position in this market during 2018–2024.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=101392240
The multimodality mammography workstations segment accounted for the largest share of the European mammography workstations market.
On the basis of modality, segmented into mammography (X-ray) workstations and multimodality mammography workstations. In 2018, the multimodality mammography workstations segment accounted for the larger share of the European mammography workstations market. This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.
The breast care centers segment is expected to register the highest growth rate in the European mammography workstations market.
On the basis of end users, segmented into hospitals, surgical clinics, & diagnostic imaging centers; breast care centers; and researchers & academia. The breast care centers segment is projected to witness the highest growth rate in the mammography workstations market during the forecast period. This can be attributed to the increased utilization of multimodal diagnostic imaging (such as PET-CT, MRI, ultrasound, and mammography) in advanced breast cancer diagnosis, rising number of breast screening programs across major European countries, increasing number of training & awareness programs to sensitize healthcare professionals about the advantages of multimodality mammography workstations, and the growing number of public-private breast care centers across key European countries.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=101392240
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
